Antigens, CD34: Clinical Trials

2 trials of Antigens, CD34, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting, 1 unknown. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Recruiting 1, Unknown 1

Follow Antigens, CD34: new trials by email Literature Review of Antigens, CD34 trials Research Report on Antigens, CD34

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase I Trial on the Safety of Delayed Infusion of a Naïve T Cell-Depleted Hematopoietic Graft With Memory T Cells in Solid Organ Transplant Recipients
Investigational cellular therapy consisting on a HSCT using a graft enriched in CD34+, depleted of naïve T-lymphocytes and supplemented with memory lymphocytes - Solid Organ Transplant Complications, Solid Organ Transplant Recipients
Phase 1RecruitingFrancisco Hernández Oliveros102025-06-102026-05-08
Autologous CD34+ Stem Cell Injection for Severe Intermittent Claudication (Leg Pain)
Autologous Stem Cells (CD34+) - Peripheral Artery Disease, Severe Intermittent Claudication
Phase 1UnknownLosordo, Douglas, M.D.242006-04-012015-03-31

Conditions studied

Intermittent Claudication (1)  ·  Peripheral Arterial Disease (1)

Sponsors

Francisco Hernández Oliveros (1)  ·  Losordo, Douglas, M.D. (1)

Countries

Spain (1)  ·  United States (1)

Top investigators

Douglas W. Losordo, M.D. (1)

Results publications

PMID 42768153